23 terminated. 23 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 23 | Terminated 23 |
| Phase 1 | 3 | Terminated 3 |
Follow Hyperlipidemias: new trials by email Literature Review of Hyperlipidemias trials Research Report on Hyperlipidemias
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of ARO-ANG3 in Participants With Homozygous Familial Hypercholesterolemia (HOFH) ARO-ANG 3 Injection - Homozygous Familial Hypercholesterolemia | Phase 2 | Terminated | Arrowhead Pharmaceuticals | 18 | 2022-04-22 | 2026-06-12 |
| Efficacy and Safety of Evinacumab in Adult Patients With Severe Hypertriglyceridemia for the Prevention of Recurrent Acute Pancreatitis evinacumab, Placebo - Hypertriglyceridemia | Phase 2 | Terminated | Regeneron Pharmaceuticals | 21 | 2021-07-12 | 2024-05-22 |
| Assess Efficacy and Safety of Epeleuton in Patients With Hypertriglyceridemia and Type 2 Diabetes DS102, Placebo - Hypertriglyceridemia, Type 2 Diabetes | Phase 2 | Terminated | Afimmune | 233 | 2020-10-13 | 2023-06-12 |
| A Gene Therapy Study for Homozygous Familial Hypercholesterolemia (HoFH) AAV directed hLDLR gene therapy - Homozygous Familial Hypercholesterolemia (HoFH) | Phase 1 / Phase 2 | Terminated | REGENXBIO Inc. | 9 | 2016-03-01 | 2023-07-13 |
| Phase 2 Study of Orlistat and SLx-4090 for the Treatment of Type 1 Hyperlipoproteinemia SLx-4090 placebo, Orlistat Placebo, Orlistat - Type 1 Hyperlipoproteinemia | Phase 2 | Terminated | University of Texas Southwestern Medical Center | 5 | 2015-11-01 | 2021-08-19 |
| Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism Adrenalectomy, Observation - Subclinical Hypercortisolism, Cushing Syndrome | Phase 2 | Terminated | National Cancer Institute (NCI) | 4 | 2013-11-27 | 2018-06-14 |
| Supplementation With Omega-3: Mechanism of Action DHA-enriched, EPA-enriched - Hypertriglyceridemia | Phase 2 | Terminated | Johns Hopkins University | 13 | 2013-04-01 | 2017-03-01 |
| Efficacy of LCQ908 on Cardiovascular Risk pradigastat (LCQ908), Placebo - Coronary Artery Disease, Hypertriglyceridemia | Phase 2 | Terminated | Novartis Pharmaceuticals | 41 | 2011-12-01 | 2016-04-14 |
| Pharmacodynamic Clinical Trial of Cardiovascular Polypill on LDL Cholesterol Cardiovascular fixed dose combination pill (acetylsalicylic acid, simvastatin and ramipril), Simvastatin, ramipril, acetylsalicylic acid - Elevated LDL Cholesterol | Phase 2 | Terminated | Ferrer Internacional S.A. | 107 | 2010-10-01 | 2013-04-24 |
| A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Low Density Lipoprotein (LDL) Cholesterol Cardiovascular fixed dose combination pill (acetylsalicylic acid, simvastatin and ramipril),, Simvastatin - Elevated LDL Cholesterol | Phase 2 | Terminated | Ferrer Internacional S.A. | 36 | 2009-09-01 | 2012-08-31 |
| IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia Atorvastatin - HIV Infections, Hyperlipidemia | Phase 1 / Phase 2 | Terminated | International Maternal Pediatric Adolescent AIDS Clinical Trials Group | 28 | 2009-08-01 | 2016-04-06 |
| Effect of Omega-3 Fatty Acid Supplementation on Hypertriglyceridemia in HIV-infected Children Omega Pure followed by placebo, Placebo followed by Omega Pure - Hypertriglyceridemia | Phase 2 | Terminated | The Hospital for Sick Children | 13 | 2008-06-01 | 2014-06-12 |
| Trial of Lovaza in Adolescents With Mild to Moderately Elevated Triglycerides Lovaza, Placebo - Hypertriglyceridemia | Phase 2 | Terminated | Boston Children's Hospital | 25 | 2008-04-01 | 2013-05-29 |
| Efficacy of Lapaquistat Acetate in Subjects With Hypercholesterolemia Lapaquistat acetate, Placebo - Hypercholesterolemia | Phase 2 | Terminated | Takeda | 224 | 2007-07-01 | 2012-05-24 |
| A Randomized, Double-Blind, Placebo-Controlled Study to Examine the Effect of Betahistine on Plasma Lipids in Patients Treated With Simvastatin Betahistine - Hypercholesterolemia | Phase 2 | Terminated | OBEcure Ltd. | 30 | 2007-05-01 | 2007-09-26 |
| Statins to Reduce D-dimer Levels in Patients With Venous Thrombosis atorvastatin, diet - Venous Thromboembolism, Hypercholesterolemia | Phase 2 | Terminated | Università degli Studi dell'Insubria | 10 | 2007-05-01 | 2011-08-19 |
| MK0859 Dose-Ranging Study (0859-003) MK0859 - Hypercholesterolemia, Mixed Hyperlipemia | Phase 2 | Terminated | Merck Sharp & Dohme LLC | 500 | 2006-06-01 | 2015-03-02 |
| Study of 3,5-Diiodothyropropionic Acid (DITPA) in Hypercholesterolemic Patients 3,5-Diiodothyropropionic acid (DITPA) therapy - Hypercholesterolemia | Phase 1 / Phase 2 | Terminated | Johns Hopkins University | 60 | 2006-04-01 | 2013-04-02 |
| Implitapide in Patients With Hypertriglyceridemia (HTG) on Maximal, Concurrent Triglyceride-Lowering Therapy implitapide - Hypertriglyceridemia | Phase 2 | Terminated | Medical Research Laboratories International | 50 | 2004-10-01 | 2005-06-24 |
| Implitapide in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) on Maximal Concurrent Lipid-Lowering Therapy Implitapide - Familial Hypercholesterolemia | Phase 2 | Terminated | Medical Research Laboratories International | 120 | 2003-10-01 | 2005-06-24 |
Showing 20 of 23. Sign in to see all of them.
Hypertriglyceridemia (8) · Hypercholesterolemia (6) · Hyperlipoproteinemia Type II (5) · Homozygous Familial Hypercholesterolemia (3) · Rare Diseases (2) · Adrenal Gland Neoplasms (1) · Adrenal incidentaloma (1) · Atherosclerosis (1) · Cardiovascular Diseases (1) · Coronary Artery Disease (1) · Cushing Syndrome (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1) · Dyslipidemias (1)
Lipid Metabolism Disorders (23) · Nutritional and Metabolic Diseases (23) · Dyslipidemias (22) · Metabolic Diseases (22) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (7) · Hyperlipoproteinemias (7) · Lipid Metabolism, Inborn Errors (7) · Metabolism, Inborn Errors (7) · Genetic Diseases, Inborn (6) · Vascular Diseases (4) · Cardiovascular Diseases (3) · Pathological Conditions, Signs and Symptoms (3) · Arterial Occlusive Diseases (2) · Arteriosclerosis (2)
Atorvastatin (3) · implitapide (3) · Aspirin (2) · Blood Circulation (2) · Ramipril (2) · Simvastatin (2) · 1-((1-(3-acetoxy-2,2-dimethylpropyl)-7-chloro-5-(2,3-dimethoxyphenyl)-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl)acetyl)piperidine-4-acetic acid (1) · 3,5-diiodothyropropionic acid (1) · 6-(4'-trifluoromethyl-6-methoxybiphenyl-2-ylcarboxamido)-1,2,3,4-tetrahydroisoquinoline-2-carboxylic acid phenyl ester (1) · Acetylcholine (1) · Adrenalectomy (1) · Betahistine (1) · Bradykinin (1) · Corn Oil (1) · Diet (1)
Medical Research Laboratories International (3) · Ferrer Internacional S.A. (2) · Johns Hopkins University (2) · Afimmune (1) · Arrowhead Pharmaceuticals (1) · Boston Children's Hospital (1) · Emory University (1) · International Maternal Pediatric Adolescent AIDS Clinical Trials Group (1) · Merck Sharp & Dohme LLC (1) · National Cancer Institute (NCI) (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · Novartis Pharmaceuticals (1) · OBEcure Ltd. (1) · REGENXBIO Inc. (1) · Regeneron Pharmaceuticals (1)
United States (18) · Canada (5) · Netherlands (5) · Israel (3) · Norway (3) · Germany (2) · Italy (2) · Australia (1) · Georgia (1) · Latvia (1) · South Africa (1) · Spain (1) · Switzerland (1)
Abhimanyu Garg, MD (1) · Ann Melvin, MD (1) · Annabelle Rodriguez, MD (1) · Ari Bitnun, MD, MSc (1) · Arshed A Quyyumi, MD (1) · Davide Imberti (1) · Dhananjay Vaidya (1) · Dhaval T Patel, M.D. (1) · Gualtiero Palareti (1) · Jason Brophy, MD (1) · Marilyn Crain, MD, MPH (1) · Markus Weissbach, MD (1)
PMID 21555712, PMID 21982664, PMID 24675657, PMID 24925526, PMID 25648989, PMID 25670366, PMID 25968622, PMID 38682459, PMID 41422812
P01HL059407 (1), R01HL079115 (1), R21DK053611 (1), U01AI068632 (1)